Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Deferred Tax Assets / Liabilities ₹-1,066 Cr₹-1,049 Cr₹-1,805 Cr₹-1,655 Cr₹-1,506 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Deferred Tax Assets / Liabilities ratio of GLENMARK PHARMACEUTICALS is ₹-1,066 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹-1,066 Cr
Mar2024₹-1,049 Cr
Mar2023₹-1,805 Cr
Mar2022₹-1,655 Cr
Mar2021₹-1,506 Cr

How is Deferred Tax Assets / Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹-1,066 Cr
Negative
Mar2024 ₹-1,049 Cr
Negative
Mar2023 ₹-1,805 Cr
Negative
Mar2022 ₹-1,655 Cr
Negative
Mar2021 ₹-1,506 Cr -

Compare Deferred Tax Assets / Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹62,362.0 Cr 1.1% 1.7% 26.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹456,989.0 Cr 1.7% 6.4% 12.1% Stock Analytics
DIVIS LABORATORIES ₹179,471.0 Cr 3% 2.8% 0.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹161,290.0 Cr 2.3% 9.1% 44.6% Stock Analytics
CIPLA ₹117,820.0 Cr 0.3% 6.1% -3.7% Stock Analytics
DR REDDYS LABORATORIES ₹114,730.0 Cr -0.1% 8.9% 1.9% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

1.1%

1.7%

26.8%

SENSEX

0.9%

4.2%

-6%


You may also like the below Video Courses